Related Experiment Video
Updated: Nov 25, 2025
07:35
Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
2.4K
Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges.
Marta Arenas-Jal1, J M Suñé-Negre1, Encarna García-Montoya1
1Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.
Comprehensive Reviews in Food Science and Food Safety
|December 16, 2020
Summary
As global populations grow and age, noncommunicable diseases present health challenges. This review examines Coenzyme Q10 (CoQ10) efficacy and safety for preventing these diseases.
Area of Science:
- Nutrition and Food Science
- Biochemistry
- Public Health
Background:
- Global population growth and aging populations present significant challenges to public health.
- Noncommunicable diseases (NCDs) are leading causes of death worldwide, necessitating preventative strategies.
- Dietary supplements are increasingly popular, highlighting the need for evidence-based efficacy and safety data.
Purpose of the Study:
- To review the scientific evidence on the efficacy and safety of Coenzyme Q10 (CoQ10).
- To explore CoQ10's potential role in managing NCDs.
- To address formulation challenges associated with CoQ10 supplements.
Main Methods:
- Literature review of scientific evidence on CoQ10.
- Analysis of studies on CoQ10's effects on NCDs.
- Examination of research on CoQ10 safety and formulation.
Main Results:
- CoQ10 is the third most consumed dietary supplement.
- Evidence suggests CoQ10's potential in treating various NCDs.
- Formulation aspects of CoQ10 require further investigation.
Conclusions:
- CoQ10 shows promise as a preventative and therapeutic agent for NCDs.
- Further research is needed to solidify CoQ10's role in public health.
- Addressing formulation challenges is crucial for optimizing CoQ10's benefits.
Related Concept Videos
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
91
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
91
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
83
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
83
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
68
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
68
01:27Cofactors and Coenzymes
85.8K
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
85.8K
01:24Cofactors and Coenzymes
12.3K
Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
12.3K
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
74
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
74